| RS2115712712 |
GNAI1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, impaired speech |
| RS2115726233 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS2115727431 |
GNAI1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, impaired speech |
| RS2115733193 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS2115742136 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS2115753236 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115753664 |
ASNS
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2115755676 |
ASNS
|
Health Risk |
Likely pathogenic |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS2115760128 |
ASL
|
Health Risk |
Conflicting classifications of pathogenicity |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS2115760718 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS2115764913 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS2115767079 |
ASL
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4C, Congenital myasthenic syndrome 4C |
| RS2115827317 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2115832531 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2115865220 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS2115874899 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115875189 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115875700 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115876295 |
COL1A2
|
Health Risk |
Likely pathogenic |
6 conditions, 6 conditions |
| RS2115877489 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Ehlers-Danlos syndrome |
| RS2115879081 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115881240 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115882062 |
ZP3
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 3, Oocyte maturation defect 3 |
| RS2115882158 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS2115885455 |
SLC26A3
|
Health Risk |
Likely pathogenic |
— |
| RS2115888140 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115890442 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115893133 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115894285 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115896730 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115898280 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS2115899372 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS2115899670 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS2115900875 |
GUSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS2115902212 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS2115902247 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS2115902456 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS2115902583 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS2115902766 |
CFTR
|
Health Risk |
Pathogenic |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS2115902837 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115903081 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS2115903565 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS2115903582 |
CFTR
|
Health Risk |
Pathogenic |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS2115914145 |
ZP3
|
Health Risk |
Pathogenic |
Empty ovarian follicle, Empty ovarian follicle |
| RS2115916781 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS2115917059 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115917155 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS2115917195 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Ehlers-Danlos syndrome |
| RS2115917238 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, arthrochalasia type |
| RS2115917306 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115917320 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115921275 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta, Ehlers-Danlos syndrome |
| RS2115921279 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS2115921523 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS2115921786 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115924241 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS2115924247 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115924490 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, arthrochalasia type |
| RS2115924495 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115927860 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115930608 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS2115931844 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, arthrochalasia type |
| RS2115931969 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2115932392 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2115933691 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115933783 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115934615 |
RELN
|
Health Risk |
Likely pathogenic |
— |
| RS2115936945 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115937116 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2115937855 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS2115937867 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2115938131 |
CFTR
|
Health Risk |
Likely pathogenic |
— |
| RS2115938731 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2115940948 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115941022 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115941300 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2115941689 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115946426 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115946490 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2115952213 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2115952631 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS2115953343 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115954840 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta, COL1A2-related disorder |
| RS2115957148 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS2115957255 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115957747 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115959456 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115959468 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2115959866 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115959912 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115959926 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115961148 |
MDFIC
|
Health Risk |
Pathogenic |
Lymphatic malformation 12, Lymphatic malformation 12 |
| RS2115961955 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS2115962248 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2115962258 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115967180 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2115969692 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2116017718 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116026958 |
GUSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS2116030305 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |